These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19056443)

  • 1. Simplifying paediatric immunization with a fully liquid DTP-HepB-Hib combination vaccine: evidence from a comparative time-motion study in India.
    Wiedenmayer KA; Weiss S; Chattopadhyay C; Mukherjee A; Kundu R; Ayé R; Tediosi F; Hetzel MW; Tanner M
    Vaccine; 2009 Jan; 27(5):655-9. PubMed ID: 19056443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants.
    Olivier C; Belohradsky BH; Stojanov S; Bonnet E; Petersen G; Liese JG
    Vaccine; 2008 Jun; 26(25):3142-52. PubMed ID: 18502545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age.
    Halperin SA; Tapiero B; Diaz-Mitoma F; Law BJ; Hoffenbach A; Zappacosta PS; Radley D; McCarson BJ; Martin JC; Brackett LE; Boslego JW; Hesley TM; Bhuyan PK; Silber JL
    Vaccine; 2009 Apr; 27(19):2540-7. PubMed ID: 19124057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four is better than nine. a combined diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenzae type b vaccine for routine immunization in Malaysia.
    Wong SL; Soosai P; Teoh YL; Han HH; Lefevre I; Bock HL
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):474-83. PubMed ID: 18564687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative clinical study to assess safety and reactogenicity of a DTwP-HepB+Hib vaccine.
    Dalvi S; Kulkarni PS; Phadke MA; More SS; Lalwani SK; Jain D; Manglani M; Garg BS; Doibale MK; Deshmukh CT;
    Hum Vaccin Immunother; 2015; 11(4):901-7. PubMed ID: 25933183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and introduction of a ready-to-use pediatric pentavalent vaccine to meet and sustain the needs of developing countries--Quinvaxem®: the first 5 years.
    Schmid DA; Macura-Biegun A; Rauscher M
    Vaccine; 2012 Sep; 30(44):6241-8. PubMed ID: 22889824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a multinational, multilingual vaccine debate on Twitter.
    Becker BF; Larson HJ; Bonhoeffer J; van Mulligen EM; Kors JA; Sturkenboom MC
    Vaccine; 2016 Dec; 34(50):6166-6171. PubMed ID: 27840012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants-A randomized study.
    Aloysia D'Cor N; Siddaiah P; Mohapatra S; Dhaded SM; I V P; Kar S; V N T; Muley P; Chhatwal J; Patnaik BN; Vidor E; Moureau A; Patel DM; Midde VJ; Jagga SR; Peesapati S; Noriega F
    PLoS One; 2023; 18(8):e0284898. PubMed ID: 37582114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on the effectiveness and impact of pentavalent vaccination program in India and other south Asian countries.
    Sreedhar S; Antony A; Poulose N
    Hum Vaccin Immunother; 2014; 10(7):2062-5. PubMed ID: 25424816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A post-marketing surveillance study of a combined diphtheria, tetanus, whole-cell pertussis, and hepatitis B vaccine in the Philippines.
    Ducusin J; Dayrit E; Simbulan A; Tuazon A
    Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):487-92. PubMed ID: 11289007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-authorization safety surveillance of a liquid pentavalent vaccine in Guatemalan children.
    Asturias EJ; Contreras-Roldan IL; Ram M; Garcia-Melgar AJ; Morales-Oquendo V; Hartman K; Rauscher M; Moulton LH; Halsey NA
    Vaccine; 2013 Dec; 31(49):5909-14. PubMed ID: 24055354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated polio vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
    Partridge S; Alvey J; Bernstein H; Blatter M; Bottenfield G; Guerrero J; Senders SD; Schuerman L; Cheuvart B; Holmes SJ
    Vaccine; 2007 Feb; 25(10):1806-13. PubMed ID: 17240493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric combined formulation DTaP-IPV/Hib vaccine.
    White C; Halperin SA; Scheifele DW
    Expert Rev Vaccines; 2009 Jul; 8(7):831-40. PubMed ID: 19538110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and reactogenicity of DTPa-HBV-IPV/Hib vaccine as primary and booster vaccination in low-birth-weight premature infants.
    Vázquez L; Garcia F; Rüttimann R; Coconier G; Jacquet JM; Schuerman L
    Acta Paediatr; 2008 Sep; 97(9):1243-9. PubMed ID: 18489623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination vaccine use and vaccination quality in a managed care population.
    Happe LE; Lunacsek OE; Marshall GS; Lewis T; Spencer S
    Am J Manag Care; 2007 Sep; 13(9):506-12. PubMed ID: 17803364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age.
    Pietrzyk JJ; Wysocki J; Pejcz J; Galaj A; Majda-Stanislawska E; Käyhty H; Thierry-Carstensen B; Jensen AM
    Vaccine; 2008 Sep; 26(41):5296-303. PubMed ID: 18675870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination against pneumococci and hepatitis B in the Dutch National Immunisation Programme].
    Boot HJ; Schouls L; Hahné S; Berbers GA; van de Laar M; Kimman TG
    Ned Tijdschr Geneeskd; 2007 Jan; 151(3):172-6. PubMed ID: 17288341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a pentavalent combination vaccine on immunization timeliness in a state Medicaid population.
    Happe LE; Lunacsek OE; Kruzikas DT; Marshall GS
    Pediatr Infect Dis J; 2009 Feb; 28(2):98-101. PubMed ID: 19148039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
    Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.